Randox founder and MD Dr Peter Fitzgerald addressing the company's Global Sales Conference this week
Randox Laboratories, the medical diagnostics company with a production facility in Dungloe, has now surpassed £1 billion in total sales.
Founded by Dr. Peter FitzGerald 34 years ago in Co. Antrim, Randox sold its first ever diagnostic blood test to Aberystwyth University Hospital. The latest sale was of highly innovative Respiratory Infection Biochips which test for multiple respiratory infections to a client in Saudia Arabia. This technology, which is unique to Randox, improves antibiotic prescribing and reduces the risk of growing antimicrobial resistance.
The major sales announcement was made at the company’s Global Sales Conference, being held this week in the Hilton Hotel, Templepatrick.
Dr. FitzGerald explained the company’s plans to build on their success. "Once operational and infrastructure costs have been met, Randox reinvests all profits into further research and development and, as a result, we have more new tests in development than any other healthcare company in the world.
"This commitment to R&D has seen the successful development and expansion of Randox patented Biochip Array Technology – greatly improving the diagnosis of a wide range of conditions. For example, we are currently working on the early and accurate diagnosis of a range of cancers, cardiovascular disease and Alzheimer’s disease.
"Our Randox Health clinics also allow newly validated tests to make a clinical impact more quickly than would normally be achieved through routine healthcare procurement processes. With our first class people, our commitment to innovation and the world class facilities we are developing at the Randox Science Park in Antrim, in Dungloe in Co Donegal, in Bangalore in India and in West Virginia in the US, we are confident that we will continue to bring our cutting-edge diagnostics to more and more people across the globe.”